Alzheimer's Disease: Difference between revisions
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
== Prevalence == | == Prevalence == | ||
Approximately 4 - 4.5 million people have Alzheimer's Disease in the United States and about 8 million affected around the world. It is expected that by 2050 that number will have increased almost three fold to around 13.2 million. The known prevalence is 6% in people over the age of 65, 20% in people over the age of 80, and more than 95% in those 95 years of age.<br> | Approximately 4 - 4.5 million people have Alzheimer's Disease in the United States and about 8 million affected around the world. It is expected that by 2050 that number will have increased almost three fold to around 13.2 million. The known prevalence is 6% in people over the age of 65, 20% in people over the age of 80, and more than 95% in those 95 years of age.<sup>1</sup><br> | ||
== Characteristics/Clinical Presentation == | == Characteristics/Clinical Presentation == |
Revision as of 02:16, 8 March 2010
Original Editors - Students from Bellarmine University's Pathophysiology of Complex Patient Problems project.
Lead Editors - Your name will be added here if you are a lead editor on this page. Read more.
Definition/Description[edit | edit source]
Alzheimer's Disease is characterized by cortical atrophy and loss of neurons, particularly in the parietal and temporal lobes. Also with loss of brain mass there is an enlargement of the ventricals of the brain.2 The changes in the brain tissue slowly cause changes in the person. Often it results in Alzheimer's dementia, however some people progress differently.
Prevalence[edit | edit source]
Approximately 4 - 4.5 million people have Alzheimer's Disease in the United States and about 8 million affected around the world. It is expected that by 2050 that number will have increased almost three fold to around 13.2 million. The known prevalence is 6% in people over the age of 65, 20% in people over the age of 80, and more than 95% in those 95 years of age.1
Characteristics/Clinical Presentation[edit | edit source]
add text here
Associated Co-morbidities[edit | edit source]
add text here
Medications[edit | edit source]
add text here
Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]
add text here
Causes[edit | edit source]
There is no know cause of Alzheimer's Disease.
Systemic Involvement[edit | edit source]
add text here
Medical Management (current best evidence)[edit | edit source]
add text here
Physical Therapy Management (current best evidence)[edit | edit source]
add text here
Alternative/Holistic Management (current best evidence)[edit | edit source]
add text here
Differential Diagnosis[edit | edit source]
add text here
Case Reports[edit | edit source]
add links to case studies here (case studies should be added on new pages using the case study template)
Resources
[edit | edit source]
Recent Related Research (from Pubmed)[edit | edit source]
see tutorial on Adding PubMed Feed
References[edit | edit source]
see adding references tutorial.
1. Goodman C, Fuller K. Pathology Implications for the Physical Therapist. St. Louis, Missouri: Saunders Elsevier; 2009.
2. Porth C. Pathopysiology Concepts of Altered Health States. Philadelphia PA: Lippincott & Wilkins; 2005.
3. Goodman C, Snyder T. Differential Diagnosis for Physical Therapists Screening for Referal. St. Louis, Missouri: Saunders Elsevier; 2007.
4. Alzheimer's Association. 2010. Available at: http://www.alz.org/index.asp . Accessed March 1, 2010.
5. Alzheimer's Disease Fact Sheet. U.S. National Institutes of Health National Institute on Aging. 2010. Available at: http://www.nia.nih.gov/Alzheimers/Publications/adfact.htm . Accessed March 1, 2010.